class="blog wp-embed-responsive wp-theme-foxiz wp-child-theme-foxiz-child supp-body td-standard-pack personalized-all menu-ani-1 hover-ani-1 btn-ani-1 btn-transform-1 is-rm-1 lmeta-dot loader-1 dark-sw-1 mtax-1 is-hd-5 is-backtop none-m-backtop is-mstick is-smart-sticky"
Consult a healthcare professional before use if pregnant, breastfeeding, taking prescription medications, or if you have a medical condition. Keep out of reach of children.
Serotonin syndrome risk. Avoid combination.
Direct serotonin precursor bypassing rate-limiting tryptophan hydroxylase step. Decarboxylated to serotonin by AAAD ubiquitously in gut and brain. In pinealocytes converted to melatonin via AANAT and ASMT. Crosses blood-brain barrier via large neutral amino acid transporter.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Antidepressants
Risk of serotonin syndrome — potentially life-threatening combination.
Management: CONTRAINDICATED. Never combine with serotonergic medications.
Antidepressants
MAO inhibition prevents serotonin degradation — severe accumulation
Antidepressant
Additive serotonergic activity; serotonin syndrome risk.
Antidepressants
Serotonin syndrome — additive serotonin precursor + reuptake inhibition
Opioid analgesics
Serotonin syndrome with serotonergic opioids
Antimigraine
Additive serotonergic effect; serotonin syndrome risk.
Parkinson's medications
Carbidopa inhibits peripheral decarboxylase — enhances CNS serotonin; vasospasm risk
Antihypertensives
Serotonin precursor + dopamine decarboxylase involvement
Data by supplement.ge — Public Health Institute of Georgia (PHIG)